6 Transforming the Drug Development Landscape
Thirteen Therapies in Trials
Targeting Alphasynuclein
Antibodies ( 4 )
Vaccines ( 2 )
Small Molecule ( 7 )
In biomedical research , we expect the majority of ideas — even promising ones — to fail . MJFF embraces calculated risk and funds a wide range of therapeutic approaches in any given area to increase “ shots on goal ” and the likelihood of success .